VCRC registered with the Supreme Council of Research Ethics

We are proud to announce that the VACSERA Clinical Research Center (VCRC) has officially received its registration with the Supreme Council of Research Ethics (CRE). This milestone cements VCRC's position as a premier clinical trials site in North Africa.

The CRE registration ensures that all Phase III and Phase IV vaccine trials, bioequivalence studies, and clinical protocols managed at the Giza facility are fully compliant with national regulations and international GCP standards.

VCRC continues to collaborate with global sponsors, NAMRU, and the WHO, facilitating medical advancements and improving regional patient access to highly advanced healthcare.